Canaccord Genuity maintains Buy on AngioDynamics; $20 target
Canaccord Genuity kept its Buy rating on AngioDynamics and reiterated a $20.00 price target, implying 78.1% upside versus the Oct 8 close of $11.23.
Story updates
12:49:20 PM UTC
SquawkNews
AngioDynamics Price Target Maintained With a $20.00/Share by Canaccord Genuity